Volume in Focus: Impax Laboratories, Warner Chilcott, Northstar Realty Finance,

Lakeway, TX -- (SBWIRE) -- 03/05/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Impax Laboratories Inc (NASDAQ:IPXL) stock fell 24.12% to $15.18 after the company yesterday announced that the U.S. Food and Drug Administration (FDA) completed its re-inspection of the Company’s Hayward manufacturing facility in connection with the previously disclosed Form 483 issued in March 2012. In addition to the re-inspection, the FDA conducted a Pre-Approval Inspection (PAI) for RYTARYTM, as analytical method validation and a portion of the stability data were generated in Hayward, and a general Good Manufacturing Practices (GMP) inspection.

How Should Investors Trade IPXL After The Solid Jump? Let’s Find Out Here

Warner Chilcott Plc (NASDAQ:WCRX) stock fell 1.96% to $13.51. The company announced that its Executive Vice President and Chief Financial Officer, Paul Herendeen, is scheduled to speak at the 2013 Goldman Sachs Leveraged Finance Healthcare Conference on Wednesday, March 6th at 1:20 p.m. EST.

Additionally, the company, on Feb. 22, announced that, it expects first quarter of 2013 revenues would start higher, and trend lower into second quarter, third quarter and fourth quarter of 2013. Analysts are expecting the Company to report revenue of $589 million for first quarter of 2013, revenue of $584 million for second quarter of 2013, revenue of $587 million for third quarter of 2013 and revenue of $581 million for fourth quarter of 2013.

Is WCRX Ready To Jump Again After The Solid Momentum? Get Free Trend Analysis Here

Northstar Realty Finance Corp. (NYSE:NRF) shares fell 0.11% to $9.02. The company, on Feb. 20, announced that it has priced an underwritten public offering of 30,000,000 shares of common stock at a public offering price of $8.39 per share. The Company has granted the underwriters a 30-day option to purchase up to 4,500,000 additional shares of common stock. The offering is expected to close on February 25, 2013. Deutsche Bank Securities and UBS Investment Bank are acting as the joint book-running managers of the offering. The Company intends to use the net proceeds of the offering to make investments relating to its business, to repurchase or pay its liabilities and for general corporate purposes.

Is NRF Buy After The Recent Price Movement? Find Out Here

About vbtrendreport.com
vbtrendreport.com’s team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by vbtrendreport.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. vbtrendreport.com does expect that investors will buy and sell securities based on information assembled and presented in vbtrendreport.com. PLEASE always do your own due diligence, and consult your financial advisor.